Background: Cynomolgus disease models that are similar to the preclinical stage of
| INTRODUC TI ON
More than 90% of diabetes is type 2 diabetes (T2DM), which is also known as adult-onset diabetes. The main age at onset ranges between 35 and 40 years. T2DM is a multifactorial metabolic disease that results from the interaction of genetic and environmental factors and is characterized by high blood glucose. Investigations of diabetes epidemiology have indicated that the incidences of diabetes and pre-diabetes are 9.7% and 15.5%, respectively, in China.
1 Prediabetes can cause adverse consequences that put an individual at great risk for overt diabetes and cardiovascular, and certain races have a higher risk. Studying the preclinical prediagnostic factors for T2DM in human patients is difficult, but these factors can be closely examined in animal models. Many factors may give rise to differences in gene expression profiling, and different T2DM model animals may produce gene expression patterns that differ from the patterns observed in human diabetes patients. Furthermore, these models may have a different influence on the development process of diabetes and relevant research studies. The genetic characteristics, life span, and endocrine system of cynomolgus monkeys (Macaca fascicularis) are similar to those of humans. 2 Additionally, spontaneous diabetes has been reported in cynomolgus monkeys, and the pathogenesis and characteristics of diabetes in these monkeys are similar to human diabetes. 3, 4 Therefore, studying gene expression profiles using a cynomolgus prediabetes model induced by a high energy diet, which simulates the human high-energy dietary constituent, is very important because the induced cynomolgus diabetes models share some phenotypic properties with human T2DM.
During the early onset of diabetes, abnormal metabolism or mutation in some genes involved in glucose and lipid metabolism or signal transduction lead to abnormal glucose tolerance, insulin resistance, and functional obstacles in pancreatic islet beta cells.
Excessive dietary fat intake is associated with an increased risk of obesity, and obesity-related genes are also related to the onset of diabetes. Excessive FTO expression in mice can increase food intake and cause obesity. 5, 6 Additionally, certain inflammatory factors play important roles in the development and progression of T2DM; these factors can cause insulin resistance and obstruction of beta cell structures and functions and lead to T2DM by interacting with endocrine adipose tissues, thereby inducing oxidative stress and an immune response. 7, 8 The TNF-α level was significantly increased in T2DM patients, which decreased the expression and transport of GLUT-4 and reduced PPARγ levels by preventing PPARγ gene expression. 9, 10 In our study, the expression patterns of genes related to glucolipid metabolism, signal transduction, and inflammation were analyzed in the preclinical phase in T2DM cynomolgus monkeys induced with different high energy diets. The study results will provide guidance and references for studies of the early diagnosis and treatment of human T2DM.
| MATERIAL S AND ME THODS

| Reagents
The 
| Animals and diets
A total of 36 slightly overweight middle-aged or aged male cynomolgus monkeys (all more than 8.5 kg and 9 years old) were supplied by Guangdong Landau Biotechnology Co., Ltd, Guangzhou, China, and 
| Body mass index calculation and detection of the serum biochemical indices
The body mass index (BMI) was calculated using the body weight divided by the square of the body length. The BMI of normal monkeys was 18.5-27 kg/m 2 and the BMI of the obese monkeys was greater than 27 kg/m 2 , which were similar to the BMIs of normal humans.
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Whole blood was collected from the hind limb veins of the monkeys and centrifuged for 5 minutes at 3000 × g to extract blood serum for the detection of the serum biochemical indices, including glucose (GLU), total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL). An additional 5 mL of blood was collected for RNA extraction from white blood cells.
| Determination of the T2DM preclinical stage in cynomolgus monkeys
The preclinical phase of T2DM in the monkeys was determined according to the fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), glucose metabolism index, and urine test results, among other factors, based on the classification standard of the preclinical stages of human diabetes.
| Primer design
According to the human diabetes PCR array (SABiosciences, America) and recent reports, 46 diabetes-associated genes were screened in this study. The primers were designed according to the exon sequences of rhesus monkeys and human mRNA. 
| Total RNA extraction, cDNA preparation and quantitative real-time PCR (RT-qPCR)
For RNA extraction, 5 mL of blood was taken from the femoral vein of cynomolgus monkeys after fasting for 14-16 hours. White blood cells were extracted from the blood, 13 and total RNA was extracted using the TRIzol method. [14] [15] [16] Then, cDNA was synthesized from 2 μg of total RNA using the EasyScript First-Strand cDNA Bio-Synthesis SuperMix (TransGen Biotech) and oligo-dT primers (Invitrogen).
Each DNA sample was amplified by PCR amplification in a 20 μL volume containing 10 μL of SYBR ® Premix Ex TaqTM (2 × ), 0. 
| Statistical analysis
After removing the reactions with no amplification, multiple Tm peaks, Ct < 8 or Ct > 35 and △Ct >13, the fold-changes in relative gene expression were analyzed using the 2 −△△CT method and normalized to GAPDH after adjusting for differences in the amplification efficiency. 17 The values were reported as the mean ± SE.
The statistical analysis was performed with one-way ANOVA in the spss 17.0 software package. P < 0.05 was considered a significant difference.
| RE SULTS
| Body conditions and serum biochemical indices
The inclusion criteria for the preclinical T2DM cynomolgus monkeys included a fasting plasma glucose (FPG) ≤5.6 mmol/L, impaired glucose tolerance (IGT, 6.1 < 2 h-PG < 10) and slight urine sugar.
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According to the above inclusion criteria and human preclinical T2DM criteria, 14 monkeys were determined to be in the preclinical T2DM stage in this study. A total of 3, 7, 4, and 6 qualified monkeys were included in the G, F, D, and C groups, respectively. The BMI, TC, TG, circulating LDL (LDL-C), and circulating HDL (HDL-C) were measured and compared as shown in Table 2 .
| Gene expression in the different induction groups
The relative mRNA expression levels of the T2DM-related genes in the cynomolgus monkeys in the preclinical T2DM phase under different dietary conditions are shown in Table 3 . A total of 22, 26, and 20 and 4, 6, and 6 genes were significantly up-and down-regulated, compared with the controls (P < 0.05). Of the 46
tested genes, the expression profiles of 22 genes were consistent. ACLY was expressed in peripheral blood leukocytes in all of the normal and several pre-diabetic monkeys. The CT value of IDE was significantly higher than GAPDH in the F and D subjects, although it appeared to be expressed at a low level; thus, the relative quantification (RQ) of this gene is represented by "N/A". The was lower (P < 0.05). The ADRB3 and NSF mRNA expression levels differed among the three groups (P < 0.05).
| D ISCUSS I ON
According to the 2006 WHO preclinical diabetes criteria for humans and previous studies on high energy diet-induced T2DM in cynomolgus macaques, the preclinical phase of cynomolgus T2DM is defined as a blood glucose value less than 5.6 mmol/L with the presence of glucose tolerance abnormities. 18, 19 According to the above conditions and referring to the diagnostic criteria of preclinical T2DM in humans, 14 cynomolgus monkeys qualified for the preclinical stage of T2DM in the three high-energy diet-induced groups, with 3, 7, and 4 qualified monkeys in the G, F, and D groups, respectively.
These results showed that all three high-energy diets induced the early symptoms of diabetes in the monkeys but that the pre-diabetes symptoms appeared more commonly in the F group than in the other two groups. The G group needed a longer time to develop early symptoms of diabetes. Because of the balanced glycolipid ratio in the D group diet, fewer monkeys exhibited preclinical diabetes symptoms during the same induction period compared with the F group.
Several epidemiological studies showed that a high fat diet was closely related to elevated LDL levels. A significant positive correlation was detected between the saturated fatty acid and serum total cholesterol levels. 20 Insufficient insulin secretion leads to blood lipid metabolism abnormalities and an increase in the CHO, and blood TG and LDL levels, which eventually cause a series of complications, such as cardiovascular disease and atherosclerosis. 21 The data from this study indicated that a glycolipid metabolism disorder occurred in three monkeys. This disorder mainly presented as a significant increase in the CHO and LDL levels compared with those of the control group; additionally, the FPG level was higher than the level in the C group. All of the profile variations, such as dyslipidemia and IGT, could give rise to changes in related gene expression. 13 Because exploring gene changes in the preclinical stage of T2DM is difficult in human patients, cynomolgus monkeys were induced to establish a diabetes model that shared some phenotypic properties with the early symptoms of human T2DM.
Catabolism is strengthened and anabolism is weakened in diabetes patients. Therefore, we selected genes related to the synthesis and regulation of blood glucose, lipids and protein expression changes. The GCGR gene was highly expressed in the liver and kidneys but weakly expressed in other tissues. Glycogen can affect GCGR expression; this gene can contain nonsense mutations that may be relevant to T2DM. Additionally, repressing GCGR activity can relieve clinical symptoms in patients with hyperglycemia. 22, 23 ACLY is the key enzyme involved in the biosynthesis of fatty acids, which can be activated by insulin. Patients with T2DM have higher or lower fatty acid concentrations than normal subjects, suggesting that ACLY activity is decreased.
PPARGC1A participates in transcriptional activation through a nuclear receptor and the metabolic regulation of the serum cholesterol levels. 24, 25 Our hypothesis was confirmed in this study.
Genes that correlated with blood glucose metabolism such as G6PC, PRKAA1, PYGL, GCCR, and PIK3C2B were significantly upregulated. Additionally, the RQs of ACLY and PRKAG2, which are involved in fat metabolism, were slightly decreased, whereas the PPARGC1 expression level, which participates in cholesterol synthesis, was obviously increased compared with that of the control group. Different degrees of change occurred in the relative quantities of other gene mRNAs, which influenced islet development, insulin resistance, signal transduction, transcriptional regulation
Measurement item
Groups with different glycolipid ratios Values are the means ± SE. *and **indicate significant differences, with P < 0.05 and P < 0.01, respectively, compared with the C group.
TA B L E 2 BMI and metabolic characteristics in the preclinical stage of T2DM cynomolgus monkeys induced by different diets
TA B L E 3 Relative mRNA expression of T2DM-related genes in the preclinical phase of cynomolgus monkeys under different dietary conditions
Gene name
GenBank accession
No. However, this hypothesis needs further investigation.
Groups with different glycolipid ratios
The diabetes PCR chip has been applied to clinical diagnosis, but its application in early risk warnings and diagnosis of diabetes needs to be further explored. We used a fluorescent quantitative polymerase chain reaction (RT-qPCR) to detect the expression patterns of diabetes-related genes in an early T2DM cynomolgus monkey model and expected to find genetic indicators that could be used for early warning, diagnosis and prognostic evaluation of T2DM.
This study narrowed the range of genes for use in genetic screening.
Because most of the genes ultimately played roles through proteins and interacted with other relative factors, the gene expression patterns at the protein level need to be confirmed in a future study.
Gene name
GenBank accession
No. Values are the means ± SE. * and ** over the bars indicate significant differences (P < 0.05) and extremely significant differences (P < 0.01), respectively, compared with the levels in the C group. N/A indicates data that were not available or had low expression levels. ↑ and ↓ show up-regulated and down-regulated expression compared with the C group.
Groups with different glycolipid ratios
Finally, these screened genes should be verified in preclinical diabetic patients to determine accurate gene indicators and to provide a more accurate and convenient detection method for the early prevention and treatment of T2DM. 
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